When you think of groundbreaking medical discoveries, a venomous lizard probably isn’t the first thing that comes to mind. But the Gila monster (Heloderma suspectum), a sluggish reptile from the southwestern U.S., holds a surprising key to modern diabetes and weight-loss treatments—including Ozempic.

From Venom to Vital Medicine

Scientists discovered that the Gila monster’s saliva contains a compound called exendin-4, which closely mimics glucagon-like peptide-1 (GLP-1)—a hormone that helps regulate blood sugar. The big difference? Unlike the human version, which breaks down quickly, exendin-4 lingers in the body much longer, making it a promising blueprint for diabetes treatments.

From a Lizard’s Bite to a Blockbuster Drug

The first medication inspired by this discovery was Exenatide (Byetta), approved in 2005 to help control blood sugar in people with type 2 diabetes. Scientists then refined the concept further, leading to the development of Ozempic (semaglutide)—a longer-lasting, more effective GLP-1 analog that also became famous for its weight-loss effects.

Nature’s Unexpected Pharmacy

While Ozempic doesn’t contain lizard venom, its development owes a debt to the unusual biology of the Gila monster. It’s yet another example of how nature continues to inspire some of the most advanced breakthroughs in medicine.